Main > PNEUMOLOGY > UK. G. COPD>Treat.>ICS+LABA+LAMA>

---

UK. G. COPD>Treat.>ICS+LABA+LAMA>'s subsections
(*) EU CE Mark Date: 2017. 11.16
(*) USA Approval Date: 2017. 09.18
>Inhalation Powder
Company
Generic ICS: Fluticasone Furoate
Generic LABA: Vilanterol
Generic LAMA: Umeclidinium
ICS: Inhaled CorticoSteroid
LABA: Long-Acting β2-Agonist
LAMA: Long-Acting Muscarinic Antag
Patent>Assignee; Claims; No.; Etc.
Patent>Total USA No.: 2
Patent>UpDate: 2021. 12.28
Product Web-Site

UK. G. COPD>Treat.>ICS+LABA+LAMA>'s products
This section has no products